View More
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Downloadable slides covering safety and efficacy data on new and emerging oral therapies for IBD, including S1PR modulators and JAK-STAT inhibitors.
Millie D. Long, MD, MPH
Released: August 24, 2021
Interactive video from Dr. Millie Long and Clinical Care Options (CCO) on new and emerging oral IBD therapies
Millie D. Long, MD, MPH
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Released: August 24, 2021
Expired:
August 23, 2022
Expert commentary from Dr. Millie Long on the benefits of and barriers to patient participation in IBD clinical trials, from Clinical Care Options (CCO)
Millie D. Long, MD, MPH
Released: August 17, 2021
Expert commentary from Dr. Millie Long on developing “activated” patients with IBD in your practice, from Clinical Care Options (CCO)
Millie D. Long, MD, MPH
Released: July 13, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.